haematology
Blood cancers

Tool can predict CAR T-cell therapy neurotoxicity

A simple tool has been developed to predict the delayed neurotoxicity that occurs in about half of patients who undergo CAR T-cell therapy. The score  – based on readily available clinical and laboratory measures – will allow observation and treatment to be targeted at those most at risk, allowing low risk patients to be discharged ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic